| GA20074-1mg |
|
122481-75-8 |
(D-Arg¹,D-Trp⁵·⁷·⁹,Leu¹¹)-Substance P
|
0 |
C81H110N20O12 |
|
|
|
| GA20073-5mg |
|
84676-91-5 |
(D-Arg¹,D-Pro²,D-Trp⁷·⁹,Leu¹¹)-Substance P
|
0 |
C75H108N20O13 |
|
|
|
| GA20073-1mg |
|
84676-91-5 |
(D-Arg¹,D-Pro²,D-Trp⁷·⁹,Leu¹¹)-Substance P
|
0 |
C75H108N20O13 |
|
|
|
| GA20072-5mg |
|
96736-12-8 |
(D-Arg¹,D-Phe⁵,D-Trp⁷·⁹,Leu¹¹)-Substance P
|
0 |
C79H109N19O12 |
|
|
|
| GA20072-1mg |
|
96736-12-8 |
(D-Arg¹,D-Phe⁵,D-Trp⁷·⁹,Leu¹¹)-Substance P
|
0 |
C79H109N19O12 |
|
|
|
| GA20071-5mg |
|
103412-36-8 |
(D-Arg⁰,Hyp³,β-(2-thienyl)-Ala⁵·⁸,D-Phe⁷)-Bradykinin
|
0 |
C56H83N19O13S2 |
|
|
|
| GA20071-1mg |
|
103412-36-8 |
(D-Arg⁰,Hyp³,β-(2-thienyl)-Ala⁵·⁸,D-Phe⁷)-Bradykinin
|
0 |
C56H83N19O13S2 |
|
|
|
| GA20070-1mg |
|
180981-09-3 |
(D-Arg⁰,Hyp³,Igl⁵,D-Igl⁷,Oic⁸)-Bradykinin
|
0 |
C64H95N19O13 |
|
|
|
| GA20070-005mg |
|
180981-09-3 |
(D-Arg⁰,Hyp³,Igl⁵,D-Igl⁷,Oic⁸)-Bradykinin
|
0 |
C64H95N19O13 |
|
|
|
| GA20069-25mg |
|
109333-26-8 |
(D-Arg⁰,Hyp³,D-Phe⁷)-Bradykinin
|
0 |
C60H87N19O13 |
|
|
|
| GA20069-5mg |
|
109333-26-8 |
(D-Arg⁰,Hyp³,D-Phe⁷)-Bradykinin
|
0 |
C60H87N19O13 |
|
|
|
| GA20068-25mg |
|
51230-19-4 |
|
0 |
C56H77N17O13 |
|
|
|
| GA20068-5mg |
|
51230-19-4 |
|
0 |
C56H77N17O13 |
|
|
|
| GA20067-25mg |
|
64854-64-4 |
(D-Ala²,N-Me-Phe⁴,methionin(O)-ol⁵)-Enkephalin
|
0 |
C29H41N5O7S |
|
|
|
| GA20067-5mg |
|
64854-64-4 |
(D-Ala²,N-Me-Phe⁴,methionin(O)-ol⁵)-Enkephalin
|
0 |
C29H41N5O7S |
|
|
|
| GA20066-100mg |
|
100929-53-1 |
(D-Ala²,N-Me-Phe⁴,glycinol⁵)-Enkephalin
|
0 |
C26H35N5O6 |
|
|
|
| GA20066-25mg |
|
100929-53-1 |
(D-Ala²,N-Me-Phe⁴,glycinol⁵)-Enkephalin
|
0 |
C26H35N5O6 |
|
|
|
| GA20065-100mg |
|
81733-79-1 |
(D-Ala²)-Leu-Enkephalin-Arg
|
0 |
C35H51N9O8 |
|
|
|
| GA20065-25mg |
|
81733-79-1 |
(D-Ala²)-Leu-Enkephalin-Arg
|
0 |
C35H51N9O8 |
|
|
|
| GA20064-1mg |
|
89453-59-8 |
(D-Ala²)-GRF (1-29) amide (human)
|
0 |
C149H246N44O42S |
|
|
|
